X37 is a startup based in the United States, most recent round Series A.
Based in the United States, X37 is a startup. Its most recent tracked round is Series A.
X37 is an AI-driven drug discovery company that uses machine learning to design therapeutics targeting difficult-to-target proteins. The company focuses on developing programs across areas including oncology, autoimmune diseases, and anticoagulation.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.